SOX2、PDCD4在垂体腺瘤组织中的表达及其意义

Abstract
Figure/Table
References
Related Citation (14)

Download: PDF (1206 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the expression and significance of SOX2 and PDCD4 in the tissues of pituitary adenoma.Methods A total of 120 patients with pituitary adenomas who were admitted to Chongqing Municipal Corps Hospital of Chinese People's Armed Police Force from June 2018 to March 2022 were selected, including 52 invasive pituitary adenomas and 68 noninvasive pituitary adenomas. The expression of SOX2 and PDCD4 was detected by immunohistochemistry; 10 cases of invasive pituitary adenoma tissues and 10 non-invasive ones were randomly selected, and the protein expression level was detected by western-blot. The value of SOX2 and PDCD4 in differentiating invasive pituitary adenoma and non-invasive pituitary adenoma was analyzed by ROC curve, and the area under the curve (AUC) was calculated. The factors affecting the invasiveness were analyzed by binary logistic regression model.Results The high expression rate and protein expression level of SOX2 in invasive pituitary adenoma tissues were 65. 38% and (1.32±0.13) respectively, which were higher than those in non-invasive pituitary adenoma tissues [27.94% and (0.38±0.08), P<0.05]. The high expression rate and protein expression level of PDCD4 in invasive pituitary adenoma tissues were 32. 69% and (0.47±0.10) respectively, which were lower than those in non-invasive pituitary adenoma tissues [51.47% and (1.09±0.11), P<0.05]. Tumor diameter, Ki-67 proliferation index, high expression of SOX2 and low expression of PDCD4 were the independent influencing factors for pituitary adenoma invasiveness (P<0.05). The AUC of SOX2 was 0.854 and PDCD4 was 0.783 in the differentiation between invasive and non-invasive pituitary adenomas, and the combination of SOX2 and SOX2 increased the AUC to 0.899.Conclusions The expression level of SOX2 is higher in the tissues of invasive pituitary adenoma, while the expression level of PDCD4 is lower, both of which have certain value in predicting the invasiveness of pituitary adenoma.

Key words： pituitary adenoma invasiveness SOX2 PDCD4

Received: 01 January 2023

ZTFLH:

R736.4

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	ZHU Mingliang
	KANG Wenbo
	LIU Zhonghong
	WANG Zhongke
	QIN Yueqi
	WEI Qihang
	ZHANG Dingrong

Cite this article:

ZHU Mingliang,KANG Wenbo,LIU Zhonghong等. Expression and significance of SOX2 and PDCD4 in pituitary adenoma tissues[J]. Med. J. Chin. Peop. Armed Poli. Forc., 2023, 34(8): 702-705.

URL:

http://journal08.magtechjournal.com/Jwk_wjyx/EN/ OR http://journal08.magtechjournal.com/Jwk_wjyx/EN/Y2023/V34/I8/702

[1]	Han C, Lin S, Lu X, et al. Tumor-associated macrophages: new horizons for pituitary adenoma researches[J]. Front Endocrinol (Lausanne), 2021, 12: 785050.
[2]	李储忠, 桂松柏, 耿素民, 等. 神经内镜经鼻入路治疗异形生长侵袭性垂体腺瘤的临床分析[J]. 中华神经外科杂志, 2022, 38(1): 5-11.
[3]	方林春, 郑苏月, 唐斌. Ki-67指数与垂体腺瘤侵袭性及复发的研究进展[J]. 中国微侵袭神经外科杂志, 2020, 25(3): 141-144.
[4]	Novak D, Hüser L, Elton J J,et al. SOX2 in development and cancer biology[J]. Semin Cancer Biol, 2020, 67(1): 74-82.
[5]	Lv L, Du J, Wang D, et al. Circular RNA hsa_circ_0026344 suppresses gastric cancer cell proliferation, migration and invasion via the miR-590-5p/PDCD4 axis[J]. J Pharm Pharmacol, 2022, 74(8):1193-1204.
[6]	Kim J Y, Lee H, Kim E K,et al. Low PDCD4 expression is associated with poor prognosis of colorectal carcinoma[J]. Appl Immunohistochem Mol Morphol, 2021, 29(9): 685-692.
[7]	Pin G, Huanting L, Chengzhan Z, et al. Down-Regulation of PDCD4 promotes proliferation, angiogenesis and tumorigenesis in glioma cells[J]. Front Cell Dev Biol, 2020, 8: 593685.
[8]	Schaefer T, Ramadoss A, Leu S, et al. Regulation of glioma cell invasion by 3q26 gene products PIK3CA, SOX2 and OPA1[J]. Brain Pathol, 2019, 29(3): 336-350.
[9]	代红伟, 杨扬, 李惺. E-cad,Snail在垂体腺瘤组织中的表达及其意义[J]. 实用癌症杂志, 2021, 36(2): 214-217.
[10]	Acitores C A, Rodríguez B V, Pian H, et al. Clinical relevance of tumor consistency in pituitary adenoma[J]. Hormones (Athens), 2021, 20(3): 463-473.
[11]	王冉, 周琦, 杨坤. 垂体腺瘤侵袭性相关指标的研究进展[J]. 临床神经外科杂志, 2021, 18(2): 226-228.
[12]	You H, Xu J, Qin X, et al. Fascin promotes the invasion of pituitary adenoma through partial dependence on epithelial-mesenchymal transition[J]. J Mol Histol, 2021, 52(4): 823-838.
[13]	Mercurio S, Serra L, Pagin M, et al. Deconstructing SOX2 function in brain development and disease[J]. Cells, 2022, 11(10): 1604.
[14]	Pouremamali F, Vahedian V, Hassani N, et al. The role of SOX family in cancer stem cell maintenance: with a focus on SOX2[J]. Pathol Res Pract, 2022, 231: 153783.
[15]	Mahlokozera T, Patel B, Chen H, et al. Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma[J]. Nat Commun, 2021, 12(1): 6321.
[16]	Zhang L H, Yin Y H, Chen H Z, et al. TRIM24 promotes stemness and invasiveness of glioblastoma cells via activating SOX2 expression[J]. Neuro Oncol, 2020, 22(12): 1797-1808.
[17]	Liu D, Ke J, Liu Y, et al. The interaction between PDCD4 and YB1 is critical for cervical cancer stemness and cisplatin resistance[J]. Mol Carcinog, 2021, 60(12): 813-825.
[18]	Wang Q, Zhu J, Wang Y W, et al. Tumor suppressor PDCD4 attenuates Sin1 translation to inhibit invasion in colon carcinoma[J]. Oncogene, 2017, 36(45): 6225-6234.
[19]	Li Y, Wang X, Wang X, et al. PDCD4 suppresses proliferation, migration, and invasion of endometrial cells by inhibiting autophagy and NF-κB/MMP2/MMP9 signal pathway[J]. Biol Reprod, 2018, 99(2): 360-372.
[20]	Matsuhashi S, Manirujjaman M, Hamajima H, et al. Control mechanisms of the tumor suppressor PDCD4: expression and functions[J]. Int J Mol Sci, 2019, 20(9): 2304.